KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) General Information

Description

Phytoextract and CBD production facilities in Switzerland. The facilities assist in producing Active Pharmaceutical Ingredients (APIs) based on phytocannabinoids and other plant extracts.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Switzerland
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland)‘s full profile, request access.

Request a free trial

KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) FAQs

  • Where is KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) headquartered?

    KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) is headquartered in Switzerland.

  • What industry is KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) in?

    KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland)’s primary industry is Buildings and Property.

  • Is KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) a private or public company?

    KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) is a Private company.

  • What is KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland)’s current revenue?

    The current revenue for KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) is .

  • When was KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) acquired?

    KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) was acquired on 12-Apr-2021.

  • Who acquired KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland)?

    KD Pharma Group (Phytoextract and CBD Production Assets in Switzerland) was acquired by KD Pharma Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process